Beijing Strong Biotechnologies Inc
SZSE:300406
Beijing Strong Biotechnologies Inc
Net Income (Common)
Beijing Strong Biotechnologies Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
Net Income (Common)
¥523.7m
|
CAGR 3-Years
67%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Net Income (Common)
-¥13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income (Common)
-¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income (Common)
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
See Also
What is Beijing Strong Biotechnologies Inc's Net Income (Common)?
Net Income (Common)
523.7m
CNY
Based on the financial report for Dec 31, 2023, Beijing Strong Biotechnologies Inc's Net Income (Common) amounts to 523.7m CNY.
What is Beijing Strong Biotechnologies Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
12%
Over the last year, the Net Income (Common) growth was 35%. The average annual Net Income (Common) growth rates for Beijing Strong Biotechnologies Inc have been 67% over the past three years , 12% over the past five years .